NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/26/2026
Back to search
Official data from USPTO
LABSAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LABSAT
ST13
US500000079261179Class
5, 9, 10
Filing
79261179
Registration
5893952
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/17/2026
Trademark type
Word
Nice classes
5, 9, 10
Filing date
02/20/2019
Registration date
10/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
Tolochenaz, CH
Examiner
CAHILL, CLARE GALLAGHER
Current location
Historical data usage
Holders and representatives
Holders
Lunaphore Technologies SA
Lunaphore Technologies SA
Representatives
Courtney Thompson Fredrikson & Byron, P.A.
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic substancespreparations and agents for medical use; diagnostic reagents and contrast media for medical use; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical use; diagnostic test reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; biotechnological preparations for medical use for the treatment of cancer and metabolic diseases
Class 9
Scientific apparatus and instrumentselectronic analyzers for testing and analyzing chemical and biological substances for the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms; optical apparatus and instrumentsmicroscopesoptical profilersoptical filtersoptical glassesoptical lens sightsoptical scannersoptical readersoptical reflectors; weighing apparatus and instrumentsscales and balances; measuring apparatus and instrumentsinstruments for measuring the quantity of contaminantspollutantsmalignant cells in animalplantmicroorganism cells and tissues; signaling apparatus and instrumentssignal processorssignal splitters for electronic apparatus; measuring and testing machines and instrumentsdigitizers; laboratory apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; microfluidic testing apparatus not for medical use in the form of assay chipsbiological assay chipssample processing chips; microfluidic systemssample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubesreservoirspumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidicsnot for medical use used to diagnose cancer; chipsintegrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chipsmicrochips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatusinstruments and devicescalculating machinescentral processing units and computers for the inputoutputtransmissionstorageprocessing of datain particular scientific and medical data relating to the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms collected via immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms collected via immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing
Class 10
Medical apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; medical apparatus and instruments for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing using fluid technology; diagnostic apparatus for medical use; microfluidic testing apparatus for medical use for testing biomarker expression levels in cell and tissue samples
Publications
History of USPTO decisions and trademark events.
26 publications found
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
02/26/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
ES71
TEAS SECTION 71 RECEIVED
10/29/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/29/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/27/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/16/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/29/2019
FIMP
FINAL DISPOSITION PROCESSED
12/29/2019
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
11/28/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2019
PUBO
PUBLISHED FOR OPPOSITION
08/13/2019
NPUB
NOTICE OF PUBLICATION
07/24/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/06/2019
DOCK
ASSIGNED TO EXAMINER
07/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/29/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/20/2019
Continuous trademark protection
Get notified about every new filing that threatens LABSAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.